Search
  • A2A Pharma

Fierce Biotech

Updated: Feb 7, 2020

Insilico and A2A launched new Deuchenne-focused AI drug company


LEARN MORE

59 views0 comments

Recent Posts

See All

Biomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations in both hematologic and solid cancers, announced the closing of

Dr. Siddhartha Mukherjee, Dr. Annalisa Jenkins and Dr. Srikumar Chellappan join A2A’s Advisory Board. LEARN MORE